Transce3nd’s AB InBev BUD Stock Holding History

Transce3nd’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-64	Closed	-$4.4K	–	292
2025 Q2	$4.4K	Hold	64	–	–	﹤0.01%	770
2025 Q1	$3.94K	Sell	64 -300	-82%	-$16.4K	﹤0.01%	761
2024 Q4	$18.2K	Buy	+364	New	+$21.1K	0.01%	587

Other funds holding BUD

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Transce3nd's BUD Position: Q3 2025 in Review

Transce3nd sold out of AB InBev (BUD) in Q3 2025, closing a stake of 64 shares — an estimated $4.4K sold.

Transce3nd first reported a position in BUD in Q4 2024 and held it in 3 quarters. The position peaked at $18.2K in Q4 2024. 483 funds tracked by Wall St. Rank hold BUD as of Q3 2025.

Transce3nd reported no remaining AB InBev position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 64 AB InBev shares in Q3 2025, an estimated $4.4K.
Transce3nd first reported a position in AB InBev in Q4 2024 and held it in 3 quarters.
Transce3nd's AB InBev position peaked at $18.2K in Q4 2024.
483 funds tracked by Wall St. Rank held AB InBev as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.